A detailed history of Pro Share Advisors LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 10,669 shares of LUNG stock, worth $93,673. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,669
Holding current value
$93,673
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$5.93 - $7.71 $63,267 - $82,257
10,669 New
10,669 $72,000
Q3 2021

Nov 12, 2021

SELL
$35.98 - $44.48 $237,072 - $293,078
-6,589 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$37.61 - $48.0 $247,812 - $316,272
6,589 New
6,589 $291,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $327M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.